Rafferty Asset Management
IRON icon

Rafferty Asset Management’s Disc Medicine IRON Stock Holding History

Rafferty Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Sell
26,566
-27,303
-51% -$1.88M ﹤0.01% 650
2026
Q1 		$3.44M Buy
53,869
+17,776
+49% +$1.23M 0.01% 493
2025
Q4 		$2.87M Sell
36,093
-1,209
-3% -$102K 0.01% 571
2025
Q3 		$2.46M Buy
37,302
+5,813
+18% +$346K 0.01% 598
2025
Q2 		$1.67M Sell
31,489
-2,552
-7% -$120K 0.01% 650
2025
Q1 		$1.69M Buy
34,041
+6,292
+23% +$350K 0.01% 621
2024
Q4 		$1.76M Sell
27,749
-8,977
-24% -$519K 0.01% 677
2024
Q3 		$1.8M Buy
36,726
+12,743
+53% +$598K 0.01% 666
2024
Q2 		$1.08M Sell
23,983
-78,882
-77% -$2.68M ﹤0.01% 804
2024
Q1 		$6.4M Buy
102,865
+63,002
+158% +$4.08M 0.02% 410
2023
Q4 		$2.3M Sell
39,863
-23,269
-37% -$1.19M 0.01% 637
2023
Q3 		$2.97M Buy
+63,132
New +$3.16M 0.02% 501

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rafferty Asset Management's IRON Position: Q2 2026 in Review

Rafferty Asset Management reduced its Disc Medicine (IRON) stake by 51% in Q2 2026, selling an estimated $1.88M and leaving 26,566 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Rafferty Asset Management first reported a position in IRON in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.4M in Q1 2024. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Rafferty Asset Management held 26,566 shares of Disc Medicine worth $1.94M as of Q2 2026.
  • Rafferty Asset Management sold 27,303 Disc Medicine shares in Q2 2026, an estimated $1.88M.
  • Disc Medicine made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #650 holding.
  • Rafferty Asset Management first reported a position in Disc Medicine in Q3 2023 and has held it in 12 quarters since.
  • Rafferty Asset Management's Disc Medicine position peaked at $6.4M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.